Nature Communications (Dec 2021)
The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression
Abstract
Mechanisms that underlie the progression of non-alcoholic fatty liver disease to the more severe non-alcoholic steatohepatitis are incompletely understood. Here the authors show that METTL3, a RNA methyltransferase that catalyzes mRNA m6 modifications, negatively regulates NASH progression via inhibiting the transcription of Cd36 and Ccl2.